206 related articles for article (PubMed ID: 27886119)
1. Synthesis and Antifungal Screening of 2-{[1-(5-Alkyl/arylalkylpyrazin-2-yl)ethylidene]hydrazono}-1,3-thiazolidin-4-ones.
Opletalova V; Dolezel J; Kunes J; Buchta V; Vejsova M; Kucerova-Chlupacova M
Molecules; 2016 Nov; 21(11):. PubMed ID: 27886119
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of novel 2-[(2,4-diaryl-3-azabicyclo[3.3.1]nonan-9-ylidene)hydrazono]-1,3-thiazolidin-4-ones as a new class of antimicrobial agents.
Ramachandran R; Rani M; Kabilan S
Bioorg Med Chem Lett; 2009 May; 19(10):2819-23. PubMed ID: 19361987
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of thiosemicarbazones with antifungal and antitumor effects: cellular iron chelation mediating cytotoxic activity.
Opletalová V; Kalinowski DS; Vejsová M; Kunes J; Pour M; Jampílek J; Buchta V; Richardson DR
Chem Res Toxicol; 2008 Sep; 21(9):1878-89. PubMed ID: 18698850
[TBL] [Abstract][Full Text] [Related]
4. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
5. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
Pfaller MA; Castanheira M; Messer SA; Jones RN
Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
[TBL] [Abstract][Full Text] [Related]
6. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
[TBL] [Abstract][Full Text] [Related]
7. Pyridine-derived thiosemicarbazones and their tin(IV) complexes with antifungal activity against Candida spp.
Parrilha GL; da Silva JG; Gouveia LF; Gasparoto AK; Dias RP; Rocha WR; Santos DA; Speziali NL; Beraldo H
Eur J Med Chem; 2011 May; 46(5):1473-82. PubMed ID: 21353348
[TBL] [Abstract][Full Text] [Related]
8. Efficient regioselective three-component domino synthesis of 3-(1,2,4-Triazol-5-yl)-1,3-thiazolidin-4-ones as potent antifungal and antituberculosis agents.
El Bialy SA; Nagy MM; Abdel-Rahman HM
Arch Pharm (Weinheim); 2011 Dec; 344(12):821-9. PubMed ID: 21932255
[TBL] [Abstract][Full Text] [Related]
9. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
[TBL] [Abstract][Full Text] [Related]
10. Novel hybrids of fluconazole and furanones: design, synthesis and antifungal activity.
Borate HB; Sawargave SP; Chavan SP; Chandavarkar MA; Iyer R; Tawte A; Rao D; Deore JV; Kudale AS; Mahajan PS; Kangire GS
Bioorg Med Chem Lett; 2011 Aug; 21(16):4873-8. PubMed ID: 21757344
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 1H-1,2,3-triazoles and study of their antifungal and cytotoxicity activities.
da Silva IF; Martins PR; da Silva EG; Ferreira SB; Ferreira VF; da Costa KR; de Vasconcellos MC; Lima ES; da Silva Fde C
Med Chem; 2013 Dec; 9(8):1085-90. PubMed ID: 23432315
[TBL] [Abstract][Full Text] [Related]
12. Isolation of the volatile fraction from Apium graveolens L. (Apiaceae) by supercritical carbon dioxide extraction and hydrodistillation: chemical composition and antifungal activity.
Marongiu B; Piras A; Porcedda S; Falconieri D; Maxia A; Frau MA; Gonçalves MJ; Cavaleiro C; Salgueiro L
Nat Prod Res; 2013; 27(17):1521-7. PubMed ID: 22974401
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antimicrobial studies of novel 2,4-diaryl-3-azabicyclo[3.3.1]nonan-9-one 4'-phenylthiosemicarbazones.
Umamatheswari S; Kabilan S
J Enzyme Inhib Med Chem; 2011 Jun; 26(3):430-9. PubMed ID: 21028943
[TBL] [Abstract][Full Text] [Related]
14. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
[TBL] [Abstract][Full Text] [Related]
15. CD101, a long-acting echinocandin, and comparator antifungal agents tested against a global collection of invasive fungal isolates in the SENTRY 2015 Antifungal Surveillance Program.
Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
Int J Antimicrob Agents; 2017 Sep; 50(3):352-358. PubMed ID: 28689871
[TBL] [Abstract][Full Text] [Related]
16. Research on antifungal and antimycobacterial agents. Synthesis and activity of 4-alkylthiopyridine-2-carbothioamides.
Klimesová V; Svoboda M; Waisser K; Machácek M; Buchta V; Odlerová Z
Arch Pharm (Weinheim); 1996 Oct; 329(10):438-42. PubMed ID: 8933745
[TBL] [Abstract][Full Text] [Related]
17. Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates.
Pfaller MA; Messer SA; Rhomberg PR; Jones RN; Castanheira M
J Antimicrob Chemother; 2016 Oct; 71(10):2868-73. PubMed ID: 27287236
[TBL] [Abstract][Full Text] [Related]
18. Antifungal susceptibility of Candida species isolated from patients with candidemia in southern Taiwan, 2007-2012: impact of new antifungal breakpoints.
Chen YC; Kuo SF; Chen FJ; Lee CH
Mycoses; 2017 Feb; 60(2):89-95. PubMed ID: 27621210
[TBL] [Abstract][Full Text] [Related]
19. Rhodanineacetic acid derivatives as potential drugs: preparation, hydrophobic properties and antifungal activity of (5-arylalkylidene-4-oxo-2-thioxo-1,3-thiazolidin-3-yl)acetic acids.
Dolezel J; Hirsova P; Opletalova V; Dohnal J; Marcela V; Kunes J; Jampilek J
Molecules; 2009 Oct; 14(10):4197-212. PubMed ID: 19924058
[TBL] [Abstract][Full Text] [Related]
20. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
